Last reviewed · How we verify
PPM Services S.A. — Portfolio Competitive Intelligence Brief
0 marketed
0 filed
2 Phase 3
0 Phase 2
0 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
| Drug | Generic | Phase | Class | Target | Area | First approval |
|---|---|---|---|---|---|---|
| N-Acetyl-GED-0507-34-Levo 5% gel | N-Acetyl-GED-0507-34-Levo 5% gel | phase 3 | Topical anesthetic | Pain management | ||
| N-Acetyl-GED-0507-34-Levo | N-Acetyl-GED-0507-34-Levo | phase 3 |
Therapeutic area mix
- Pain management · 1
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
Subscribe to ongoing alerts
Every new pipeline event for PPM Services S.A.:
- PPM Services S.A. pipeline updates — RSS
- PPM Services S.A. pipeline updates — Atom
- PPM Services S.A. pipeline updates — JSON
Cite this brief
Drug Landscape (2026). PPM Services S.A. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/ppm-services-s-a. Accessed 2026-06-10.